Results 221 to 230 of about 123,600 (352)
Disordered Immune Regulation and its Therapeutic Targeting in Myelodysplastic Syndromes
Kathryn S. Ivy, P. Brent Ferrell
openalex +2 more sources
Hematopathology Practice in the Digital Era: What has Changed?
ABSTRACT Hematopathology workflows are complex, since they include numerous data points necessary for guiding further testing, diagnosis, and patient management. The workflows start with complete blood cell counts, with subsequent morphologic evaluation of peripheral blood (PB) and bone marrow (BM).
Olga Pozdnyakova
wiley +1 more source
Fabry Disease Associated With Myelodysplastic Syndrome: Case Report. [PDF]
Zheng L +5 more
europepmc +1 more source
ABSTRACT The recent fifth edition WHO classification and ICC classification systems have moved further toward genetically defined classifications of acute leukemias. Both now recognize myelodysplasia‐related (MR) mutations as defining of MDS‐related AML (AML‐MR).
Timothy J. Kirtek, Olga K. Weinberg
wiley +1 more source
The development of intrapulmonary shunting caused by luspatercept in low grade myelodysplastic syndrome: a case report. [PDF]
Frisch A, Wilkinson JD, Nyquist AS.
europepmc +1 more source
ABSTRACT Hematologic emergencies are urgent health conditions which result in significant mortality and morbidity unless timely therapeutic measures are taken. Therapeutic success depends on their timely and accurate recognition by hematology laboratory services.
Ganna Shestakova +2 more
wiley +1 more source
Concurrent <i>SF3B1</i> Mutation and <i>BCR::ABL1</i> Demonstrating a Myelodysplastic Syndrome Phenotype: A Case Report. [PDF]
Brailovski E +6 more
europepmc +1 more source
Unexplained Elevated Vitamin B12: Consider Macro‐B12
ABSTRACT Introduction Elevated vitamin B12 concentration can be caused by supplementation, liver disease, kidney disease, or myeloid malignancies. Persistent, unexplained elevations of vitamin B12 can raise concern among patients and may lead to invasive diagnostic procedures, including bone marrow biopsy.
Evelien G. E. Hurkmans +3 more
wiley +1 more source

